Mogamulizumab-kpkc Intravenous and Sandostatin LAR
Determining the interaction of Mogamulizumab-kpkc Intravenous and Sandostatin LAR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: octreotide
Brand name: Sandostatin, Sandostatin LAR Depot
Synonyms: Octreotide (injection), Octreotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Sandostatin LAR Depot
- Mogamulizumab-kpkc Intravenous-Sandostatin LAR Depot injection
- Mogamulizumab-kpkc Intravenous-Sani-Supp
- Mogamulizumab-kpkc Intravenous-Sani-Supp rectal
- Mogamulizumab-kpkc Intravenous-Sansert
- Mogamulizumab-kpkc Intravenous-Santyl
- Sandostatin LAR-Molindone
- Sandostatin LAR-Mometasone (Oral Inhalation)
- Sandostatin LAR-Mometasone and Formoterol
- Sandostatin LAR-Mometasone and formoterol Inhalation
- Sandostatin LAR-Mometasone Cream
- Sandostatin LAR-Mometasone Furoate